Ustell (Star Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Ustell drug offered from Star Pharmaceuticals LLC. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Star Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2010-09-27 |
END MARKETING DATE: | 0000-00-00 |
Ustell HUMAN PRESCRIPTION DRUG Details:
Item Description | Ustell from Star Pharmaceuticals LLC |
LABELER NAME: | Star Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 120; 40.8; 36; 10; .12(mg/1; mg/1; mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2010-09-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0076-0903_45c7c55c-ce7d-1f92-e054-00144ff8d46c |
PRODUCT NDC: | 0076-0903 |
APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers: